Repligen
RGEN
507 hedge funds and large institutions have $12.5B invested in Repligen in 2021 Q4 according to their latest regulatory filings, with 87 funds opening new positions, 155 increasing their positions, 181 reducing their positions, and 54 closing their positions.
61% more first-time investments, than exits
New positions opened: 87 | Existing positions closed: 54
6% more funds holding
Funds holding: 478 → 507 (+29)
0.56% less ownership
Funds ownership: 86.05% → 85.49% (-0.56%)
9% less capital invested
Capital invested by funds: $13.6B → $12.5B (-$1.19B)
14% less call options, than puts
Call options by funds: $57.4M | Put options by funds: $66.6M
14% less repeat investments, than reductions
Existing positions increased: 155 | Existing positions reduced: 181
25% less funds holding in top 10
Funds holding in top 10: 12 → 9 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$199M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$134M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$129M |
| 4 |
Impax Asset Management Group
London,
United Kingdom
|
+$52.6M |
| 5 |
Millennium Management
New York
|
+$50.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$227M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$120M |
| 3 |
FAM
Fred Alger Management
New York
|
-$95.7M |
| 4 |
Select Equity Group
New York
|
-$87.9M |
| 5 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
-$58.6M |
RGEN Hedge Fund Activity: Q4 2021 in Review
507 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Repligen (RGEN) for Q4 2021, worth a combined $12.5B — down 8.7% from $13.6B a quarter earlier.
Buyers outnumbered sellers: 87 funds opened new RGEN positions and 54 closed out — a net gain of 33 holders — while 155 added to existing stakes and 181 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $199M. The largest seller was Wells Fargo, cutting an estimated $227M.
- 507 institutional investors held Repligen (RGEN) as of Q4 2021, up from 478 in Q3 2021.
- Funds reported $12.5B of Repligen stock for Q4 2021, down 8.7% quarter-over-quarter.
- 87 funds opened new Repligen positions in Q4 2021 and 54 closed out, a net change of +33 holders.
- The largest Repligen buyer in Q4 2021 was T. Rowe Price Associates, an estimated $199M added.
- The largest Repligen seller in Q4 2021 was Wells Fargo, an estimated $227M sold.
Based on aggregated 13F filings for Q4 2021.